October 2023 Top Biopharma Deal: Daiichi Sankyo co-development and commercialization deal with Merck for 3 antibody-drug conjugates

by Chris Dokomajilar | Nov 2, 2023 | Deal of the Month

September 2023 Top Biopharma Deal: Immatics development and commercialization deal with Moderna for TCR therapies

by Chris Dokomajilar | Oct 2, 2023 | Deal of the Month

August 2023 Top Biopharma Deal: Poseida license option deal with Astellas for P-MUC1C-ALLO1

by Chris Dokomajilar | Sep 5, 2023 | Deal of the Month, Partnership Deals

July 2023 Top Biopharma Deal: Alnylam co-development and co-commercialization deal with Roche for zilebesiran

by Chris Dokomajilar | Aug 1, 2023 | Deal of the Month, Partnership Deals

June 2023 Top Biopharma Deal: AstraZeneca research partnership with Quell Therapeutics with an option to license Treg cell therapies

by Chris Dokomajilar | Jul 3, 2023 | Deal of the Month

May 2023 Top Biopharma Deal: Cellular Biomedicine development and commercialization deal with Janssen for C-CAR039 and C-CAR066

by Chris Dokomajilar | Jun 1, 2023 | Deal of the Month